Jasper Therapeutics Inc. JSPR

$0.51 0.00 (-0.90%)

Valuation

Market cap
16,970,000
Revenue TTM
$0
Net income TTM
$-75,800,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
396,700
Avg volume
444,334
Day's range
$0.50 – $0.52
Shares out
33,275,000
Stochastic %K
50%
Beta
3.16
Analysts
Strong Sell
Price target
$6.25

Price

Company profile

Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. It is advancing a pipeline of medicines, including KP-104, a dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal nocturnal hemoglobinuria (PNH) and is under evaluation in other unmet need nephrology disorders; Briquilimab is an anti-KIT an...

Show more

Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. It is advancing a pipeline of medicines, including KP-104, a dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal nocturnal hemoglobinuria (PNH) and is under evaluation in other unmet need nephrology disorders; Briquilimab is an anti-KIT antibody, which has demonstrated clinical results as a conditioning agent for stem cell transplant and mast cell mediated diseases, such as chronic urticarias and allergic asthma; and KP-701, a novel, dual-acting anti-CD79BxCD32B monoclonal antibody (mAb) for autoantibody-mediated disorders. The company is based in Redwood City, California.

Industry
Biotechnology
Sector
Healthcare
Phone
650-549-1400
Website
https://jaspertx.com
Address
2200 Bridge Pkwy, Suite #102, Redwood City, United States

Latest news

Stocktwits

Chrissytina Oct 23, 11:35 PM
$JSPR Come Monday…
3 replies
focafoca99 Oct 15, 12:18 PM
$JSPR wrapped up enrollment of its IgA nephropathy cohort in a Phase 2 basket study of vensobafusp alfa.
0 replies
Mario19860 Oct 14, 5:32 PM
$JSPR last two years only drop
0 replies
Biobio4 Oct 13, 8:21 PM
$JSPR 10% on no news :/
0 replies
JPetermanAZ Oct 8, 9:58 PM
$JSPR most boring stock i own-----like watching paint dry-------throw her on the loss heap with the others
0 replies
flychicken1991 Oct 7, 1:52 PM
$JSPR All outstanding warrants are eligible for Jasper Therapeutics (JSPR)'s cash purchase offer. - Stock Titan. Impact: Mixed (88%). JSPR's valuation could benefit from reduced potential dilution if warrants are repurchased, while the associated cash expenditure could pressure the stock by reducing funds available for operations. Source and what to watch next: https://nimpact.tech/newsimpact/news/98f5344691ba04de/jspr-all-outstanding-warrants-are-eligible-for-jasper-therapeutics-jspr?utm_source=stocktwits&utm_medium=story_url
0 replies
focafoca99 Oct 7, 12:37 PM
$JSPR opened a cash tender offer for its outstanding warrants at $0.324 per warrant, closing Nov 6.
0 replies
Stock_Catcher Oct 7, 12:00 PM
$JSPR Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants
0 replies